These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 33724462)
1. Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen. Cowan RP; Gross NB; Sweeney MD; Sagare AP; Montagne A; Arakaki X; Fonteh AN; Zlokovic BV; Pogoda JM; Harrington MG Headache; 2021 Mar; 61(3):536-545. PubMed ID: 33724462 [TBL] [Abstract][Full Text] [Related]
2. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study. Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869 [TBL] [Abstract][Full Text] [Related]
3. Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design. Serrano D; Lipton RB; Scher AI; Reed ML; Stewart WBF; Adams AM; Buse DC J Headache Pain; 2017 Oct; 18(1):101. PubMed ID: 28980171 [TBL] [Abstract][Full Text] [Related]
4. Plasma and cerebrospinal fluid inflammation and the blood-brain barrier in older surgical patients: the Role of Inflammation after Surgery for Elders (RISE) study. Vasunilashorn SM; Ngo LH; Dillon ST; Fong TG; Carlyle BC; Kivisäkk P; Trombetta BA; Vlassakov KV; Kunze LJ; Arnold SE; Xie Z; Inouye SK; Libermann TA; Marcantonio ER; J Neuroinflammation; 2021 Apr; 18(1):103. PubMed ID: 33931093 [TBL] [Abstract][Full Text] [Related]
5. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. Lipton RB; Serrano D; Nicholson RA; Buse DC; Runken MC; Reed ML Headache; 2013; 53(10):1548-63. PubMed ID: 23992516 [TBL] [Abstract][Full Text] [Related]
6. Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study. Süße M; Kloetzer C; Strauß S; Ruhnau J; Overeem LH; Bendig M; Schulze J; Reuter U; Vogelgesang A; Fleischmann R J Headache Pain; 2024 Apr; 25(1):46. PubMed ID: 38561692 [TBL] [Abstract][Full Text] [Related]
7. Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine. Cernuda-Morollón E; Martínez-Camblor P; Alvarez R; Larrosa D; Ramón C; Pascual J Cephalalgia; 2015 Apr; 35(4):310-6. PubMed ID: 24847167 [TBL] [Abstract][Full Text] [Related]
8. Assessment of peripheral biomarkers potentially involved in episodic and chronic migraine: a case-control study with a focus on NGF, BDNF, VEGF, and PGE2. Mozafarihashjin M; Togha M; Ghorbani Z; Farbod A; Rafiee P; Martami F J Headache Pain; 2022 Jan; 23(1):3. PubMed ID: 34991456 [TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide, VE-cadherin, HMGB1, and HIF-1α levels are elevated in the systemic circulation in chronic migraine patients with medication overuse headache: evidence of leaky gut and inflammation. Vuralli D; Ceren Akgor M; Gok Dagidir H; Gulbahar O; Yalinay M; Bolay H J Headache Pain; 2024 Feb; 25(1):23. PubMed ID: 38369488 [TBL] [Abstract][Full Text] [Related]
10. Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study. Lipton RB; Serrano D; Pavlovic JM; Manack AN; Reed ML; Turkel CC; Buse DC Headache; 2014 May; 54(5):830-49. PubMed ID: 24527745 [TBL] [Abstract][Full Text] [Related]
12. Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis. van Dongen RM; Zielman R; Noga M; Dekkers OM; Hankemeier T; van den Maagdenberg AM; Terwindt GM; Ferrari MD Cephalalgia; 2017 Jan; 37(1):49-63. PubMed ID: 26888294 [TBL] [Abstract][Full Text] [Related]
13. Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine. Ashina M; Cohen JM; Gandhi SK; Du E Headache; 2021 Jun; 61(6):916-926. PubMed ID: 34115380 [TBL] [Abstract][Full Text] [Related]
14. Prospective cohort study of routine exercise and headache outcomes among adults with episodic migraine. Hagan KK; Li W; Mostofsky E; Bertisch SM; Vgontzas A; Buettner C; Mittleman MA Headache; 2021 Mar; 61(3):493-499. PubMed ID: 33349935 [TBL] [Abstract][Full Text] [Related]
15. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results. Reed ML; Fanning KM; Serrano D; Buse DC; Lipton RB Headache; 2015 Jan; 55(1):76-87. PubMed ID: 25250833 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Inflammatory State in Migraineurs: A Case-control Study. Togha M; Razeghi Jahromi S; Ghorbani Z; Ghaemi A; Rafiee P Iran J Allergy Asthma Immunol; 2020 May; 19(S1):83-90. PubMed ID: 32534515 [TBL] [Abstract][Full Text] [Related]
17. Similarities and differences between chronic migraine and episodic migraine. Ferrari A; Leone S; Vergoni AV; Bertolini A; Sances G; Coccia CP; Ottani A; Pinetti D; Sternieri E Headache; 2007 Jan; 47(1):65-72. PubMed ID: 17355496 [TBL] [Abstract][Full Text] [Related]
18. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872 [TBL] [Abstract][Full Text] [Related]
19. Role of adipocytokines in the pathophysiology of migraine: A cross-sectional study. Domínguez C; Vieites-Prado A; Pérez-Mato M; Sobrino T; Rodríguez-Osorio X; López A; Campos F; Martínez F; Castillo J; Leira R Cephalalgia; 2018 Apr; 38(5):904-911. PubMed ID: 28677995 [TBL] [Abstract][Full Text] [Related]
20. Increased serum prolactin level may indicate more migraine attack frequency. Togha M; Nematgorgani S; Ghorbani Z; Rafiee P; Haghighi S Brain Behav; 2023 Jul; 13(7):e3063. PubMed ID: 37190874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]